Back to Search Start Over

Seasonal affective disorder and non-seasonal affective disorders: Results from the NESDA study

Authors :
Willem A. Nolen
Ybe Meesters
Wim H. Winthorst
Annelieke M. Roest
Peter de Jonge
Elisabeth H. Bos
Brenda W.J.H. Penninx
Developmental Psychology
Clinical Cognitive Neuropsychiatry Research Program (CCNP)
Psychiatry
APH - Mental Health
APH - Digital Health
Interdisciplinary Centre Psychopathology and Emotion regulation (ICPE)
Source :
Winthorst, W H, Roest, A M, Bos, E H, Meesters, Y, Penninx, B W J H, Nolen, W A & de Jonge, P 2017, ' Seasonal affective disorder and non-seasonal affective disorders: results from the NESDA study ', BJPSYCH OPEN, vol. 3, no. 4, pp. 196-203 . https://doi.org/10.1192/bjpo.bp.116.004960, Neuropsychobiology, 76(1), 38-39. KARGER, BJPSYCH OPEN, 3(4), 196-203. Cambridge University Press, BJPsych Open, 3(4), 196-203. ROYAL COLL PSYCHIATRISTS, BJPsych Open
Publication Year :
2017
Publisher :
Royal College of Psychiatrists, 2017.

Abstract

BACKGROUND: Seasonal affective disorder (SAD) is considered to be a subtype of depression.AIMS: To compare the clinical picture of SAD to non-seasonal affective disorders (non-SADs).METHOD: Diagnoses according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) were established in 2185 participants of the Netherlands Study of Depression and Anxiety. The Seasonal Pattern Assessment Questionnaire was administered to diagnose SAD. Symptoms of depression and anxiety were measured with the Inventory of Depressive Symptoms, the Beck Anxiety Inventory and the Fear Questionnaire.RESULTS: Participants with SAD, participants with a lifetime bipolar disorder and participants with a lifetime comorbid anxiety and depressive disorder scored highest in terms of psychopathology in the past year. The seasonal distribution of major depressive episodes was not different for participants with or without SAD.CONCLUSIONS: SAD may be a measure of severity of depression with a subjectively perceived worsening of symptoms in the winter months.DECLARATION OF INTEREST: Y.M. has received research funding and served as a consultant for Royal Philips Electronics NV and The Litebook Company Ltd. W.A.N. has received grants from the Netherlands Organization for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth; has received honoraria/speaker's fees from Astra Zeneca, Pfizer, Servier and Wyeth; and has served in advisory boards for Astra Zeneca, Pfizer and Servier.COPYRIGHT AND USAGE: © The Royal College of Psychiatrists 2017. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license.

Details

ISSN :
20564724 and 0302282X
Volume :
3
Database :
OpenAIRE
Journal :
BJPsych Open
Accession number :
edsair.doi.dedup.....5f1156f0c45fd88be02900ff760805bb